Understanding Omicron and Vaccine Trials for Young Children

This chapter explores the varying severity of Omicron symptoms in children compared to adults, noting that while generally milder than Delta, some children face severe symptoms requiring hospitalization. It also discusses the adjustments made in COVID-19 vaccine trials for children under five and the continued prevalence of COVID-19 relative to influenza, stressing the need for protective measures for young children.